|9 Months Ended|
Sep. 30, 2021
NOTE H – CAPITAL STOCK
The Company has authorizedshares of preferred stock, with a par value of $ per share. Of those shares, the Company has authorized shares as Series A preferred stock and shares as Series B preferred stock. At September 30, 2021 and December 31, 2020, there were shares of Series A and shares of Series B outstanding, respectively.
As of September 30, 2021, the Company had authorizedshares of common stock with a par value of $.001 per share. As of September 30, 2021 and December 31, 2020, the Company had common shares issued and outstanding.
During the nine months ended September 30, 2021, the Company did not issue any shares of common stock. During the three months ended September 30, 2020, the Company issued 18,000, which approximated the fair value of the shares when they were issued.shares of common stock to directors for services performed during the three months ended September 30, 2020. The shares issued for the three months ended September 30, 2020 were valued at $
During the three and nine months ended September 30, 2021 and 2020,warrants were exercised. These warrants were originally granted to shareholders of the April 8, 2011 Series B preferred stock issuance.
During the three and nine months ended September 30, 2021 and 2020,shares of Series A or B preferred stock were converted to shares of common stock.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef